Progentics
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Hashikma St, Azor, Tel Aviv, IsraelPhone Number
+972 35541464Website
www.progenetics.co.ilRevenue
<$5 MillionIndustry
About Progentics
Progentics Org Chart
Is Progentics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Progentics recently announced quarterly report
Check if Progentics has recently received funding, and reach out quickly before it becomes old news!
Progentics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Progentics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Progentics has new funding data
Product Launch: Get notified when Progentics launches new products
Congratulate Masked Content for being promoted to Masked Content at Progentics
Check out if Progentics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Progentics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Progentics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Progentics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Progentics.
Progentics Tech Stack
A closer look at the technologies used by Progentics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Progentics
Progentics specializes in advanced genetic testing for personalized cancer treatment, utilizing comprehensive molecular profiling and AI-based insights. Their innovative tests provide critical information for precise and tailored medical decision-making, from assessing cancer recurrence risk to matching targeted therapies. This empowers both physic... Read More